Literature DB >> 32894328

Change over time in the surgical management of pelvic organ prolapse between 2008 and 2014 in France: patient profiles, surgical approaches, and outcomes.

Mathilde Hendriks1,2, Stéphanie Bartolo3,4, Géraldine Giraudet5, Michel Cosson5,6, Emmanuel Chazard4.   

Abstract

INTRODUCTION AND HYPOTHESIS: Pelvic organ prolapse (POP) is a common pathological condition that may require surgical management. Several surgical treatment options are possible, and practice varies from one center to another. The objective of the present study was to describe the surgical management and outcomes of POP in France from 2008 to 2014.
METHODS: We performed a retrospective cohort study of all patients operated on for POP from 2008 to 2014, according to the French national hospital discharge summary database. Patient characteristics, surgical approaches, concomitant hysterectomy and/or incontinence surgery, the length of stay, the proportion of day-case operations, and patient outcomes were analyzed.
RESULTS: We analyzed 310,938 hospital stays with POP surgery between 2008 and 2014; 130,908 (42%) of the operations took place in hospitals performing more than 100 prolapse surgical procedures per year. The proportion of day-case operations was low, but rose significantly from 1.2% to 4.6% during the study period. More than half of the operations featured a vaginal approach. The proportions of operations with concomitant hysterectomy or urinary incontinence surgery fell from 41.0% to 36.1% and from 33.0% to 25.8% respectively. The proportions of laparoscopic procedures increased. The mortality rate was stable (0.07% for all years).
CONCLUSIONS: The number of patients undergoing POP surgery remained stable from 2008 to 2014. The proportion of laparoscopic procedures increased (in parallel with the rising proportion of day-case operations) and the proportion of procedures with concomitant hysterectomy or incontinence treatment decreased.

Entities:  

Keywords:  Hysterectomy; Pelvic organ prolapse; Urinary incontinence

Year:  2020        PMID: 32894328     DOI: 10.1007/s00192-020-04491-2

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  1 in total

1.  Risk factors for failure of transvaginal sacrospinous uterine suspension in the treatment of uterovaginal prolapse.

Authors:  Tzu-Yin Lin; Tsung-Hsien Su; Yeou-Lih Wang; Mei-Yu Lee; Ching-Hung Hsieh; Kuo-Gon Wang; Gin-Den Chen
Journal:  J Formos Med Assoc       Date:  2005-04       Impact factor: 3.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.